Abstract | The prevalence and severity of pediatric obesity have dramatically increased since the late 1980s, raising concerns about a subsequent increase in cardiovascular outcomes. Strong evidence, particularly from autopsy studies, supports the concept that precursors of adult cardiovascular disease (CVD) begin in childhood, and that pediatric obesity has an important influence on overall CVD risk. Lifestyle patterns also begin early and impact CVD risk. In addition, obesity and other CVD risk factors tend to persist over time. However, whether childhood obesity causes adult CVD directly, or does so by persisting as adult obesity, or both, is less clear. Regardless, sufficient data exist to warrant early implementation of both obesity prevention and treatment in youth and adults. In this Review, we examine the evidence supporting the impact of childhood obesity on adult obesity, surrogate markers of CVD, components of the metabolic syndrome, and the development of CVD. We also evaluate how obesity treatment strategies can improve risk factors and, ultimately, adverse clinical outcomes.
Introduction
The prevalence and severity of obesity, defined as BMI >95 th percentile for age, 1 has increased dramatically for all age groups over the past 30 years.
2 Obesity preva lence rose from approximately 5% to 17% in children and adoles cents over this time period, 2 and has subse quently been linked with increasing prevalence of type 2 diabetes mellitus (T2D), hypertension, and athero sclerosis. [3] [4] [5] [6] This trend in childhood obesity raises con cerns about accelerated development of cardiovascular disease (CVD), and the need to prevent such adverse outcomes. Few longitudinal studies specifically link childhood obesity to CVD outcomes in adulthood, as the gradual athero sclerotic process takes decades to evalu ate. Nevertheless, three major lines of evidence support the relationship between childhood obesity and adverse outcomes later in life. First, childhood obesity is likely to persist into adulthood, parti cularly when the child is older at the time of evaluation, severely obese, or has a family history of obesity (Table 1) . Persistence of obesity is important because adult obesity is clearly associated with increased rates of CVD. 7 Secondly, a crosssectional association exists between childhood obesity and risk factors for CVD, such as insulin resistance, hyper tension, dyslipidemia, hepatic and visceral adi posity, and inflammation, and between childhood obesity and inter mediate surrogate markers of CVD progression such as vascular imaging and measures of vascular stiffness. These variables also tend to persist over time, suggest ing that highrisk status, once reached, is maintained. This line of evidence is bolstered by research demonstrating that the absence of risk factors confers substantial life time protection from CVD. Moreover, in most studies, weight loss not only favorably modifies CVD risk, but some reversibility of early onset vascular wall changes can be demonstrated.
8, 9 The third, moredirect line of evidence comes from studies providing longitudinal views of the relationship between childhood obesity and actual adverse CVD outcomes in adulthood. [10] [11] [12] In this Review, we examine the evidence supporting the impact of childhood obesity on CVD development and explore the metabolic consequences of pediatric obesity, indicat ing mechanisms that increase CVD risk (Figure 1 ). We also evaluate the effects of strategies for the treatment of obesity on risk factors for CVD and, ultimately, adverse clinical outcomes.
A predictor of adult obesity
Numerous longitudinal studies conducted worldwide (Table 1) demonstrate that obesity persists from childhood into adulthood; the risk of adult obesity increases with rising severity of childhood obesity and age. 12 However, data indicate that childhood obesity can be reversible. 13 Although lean youths have a lower risk of becoming obese as adults than obese youths, the current high prevalence of adult obesity means that all young people are currently at risk for adult obesity, 2 which indicates that population wide public health initiatives and targeted riskfactor based approaches toward preventing adult obesity are needed. The independent association between childhood obesity and adult CVD is less clear, however, as adverse adult CVD profiles could result from persistence of obesity over many years rather than from the independent effects of childhood obesity.
Birth weight
Various cutoff points for 'high' and 'low' birth weight have been used in practice. However, importantly, this variable is a continuum and we have not referred to exact cutoff points to emphasize the continuous nature of birth weight as a risk factor. High birth weight, parti cularly in association with maternal gestational diabetes, is associ ated with obesity in childhood and adulthood (Box 1). For example, among 252,961 Danish youths born between 1936 and 1983, the proportion of individuals who were overweight at ages 6-13 years increased consistently with each increase in birthweight category. 15 In the Bogalusa Heart Study, the offspring of parents with T2D, especially black females, had significantly higher birth weight, weight at all ages, and (independent of adult weight) higher levels of insulin, glucose, tri glycerides, VLDL cholesterol, and LDL chol esterol in adulthood. 16 Among 506 indivi duals from South India, high ponderal index (kg/m 3 ) was associ ated with T2D at ages 39-60 years. 17 Whereas high birth weight seems to predict pediatric and adult obesity, low birth weight and thinness during infancy are linked to reduced lean body mass and to adulthood visceral adipo sity, hypertension, CVD, and T2D, potentially owing to permanent changes in hormone secretion or sensitivity. 18 Thus, a 'ushaped' curve for the relationship between birth weight and later obesity seems to exist. In the Bogalusa Heart Study, birth weight was inversely associated with systolic blood pressure (SBP) and diastolic blood pressure (DBP). 19 Determinants of infant body composition such as fat mass, lean mass, and visceral and hepatic adi posity, in addition to birth weight alone, will allow moresubtle dis section of these relationships. Further research is required on the relationship between potentially avoidable precon ception and prenatal maternal factors, such as maternal diet, lipemia, glycemia, and activity levels that impact birth weight, length, and body composition, and how they influ ence the risk of obesity and CVD in adulthood.
Patterns of weight change
Studies of birth weight support a relationship between prenatal factors and later obesity. However, the results of the Danish study discussed above also argue for early post natal environmental influences because the obesity rates increased even though the birth rate distribution remained stable over the study period. 15 In some studies, an early postinfancy BMI rebound (age <5.5 years for boys and <5 years for girls) correlated with increased adult BMI, and could be an important modifiable, postnatal factor. 20, 21 In a longitudinal study of 8,760 people born in Helsinki, Finland between 1934 and 1944, both low weight gain between birth and 1 year of age, and early BMI rebound, predicted later adult obesity and T2D. 22 However, Freedman et al. reported that the association between BMI rebound and adult obesity was not independent of childhood BMI in the Bogalusa Heart Study; 23 therefore, the importance of BMI rebound remains controversial. Another modifiable early postnatal factor that has not yet been studied and is deserving of research is whether the standard highcalorie supplementation in infants and tod dlers of low BMI or low birth weight is beneficial or could actually promote later obesity and CVD.
Physical activity
Another factor affecting adult weight is physical activity level in childhood. In a cohort of 1,319 youths who were followedup for 21 years in the Young Finns study, both decreasing activity level and persistent inactivity over time predicted adult obesity. 24 Physical inactivity persisted more strongly than physical activity, and constantly active individuals had a better coronary risk profile than those who were constantly inactive. 25 Maintaining a high level of physical activity from youth to adulthood was indepen dently protective of abdominal obesity in women, but not in men. 24 These findings suggest that declining physical activity over time could contribute to the development of abdominal obesity in women. Maximal exercise capacity is reduced in obese youths, and even more substantially in those who also have T2D. 26 However, whether obesity or diabetes reduce the ability to exercise, or whether intrinsic abnormalities limiting ability to exercise increase risk for obesity and hyperglycemia, is yet to be determined.
Links with surrogate CVD markers CVD events remain rare in pediatric studies unless large cohorts are followed for more than 30-40 years. Although such cohorts are invaluable, and are required for defini tive conclusions, practicality and cost often mandate the initial use of surrogate CVD markers as alternatives to actual CVD events. In adults, CVD biomarkers are useful at multiple points along the pathophysio logical pathway as indicators of disease traits, disease state, rate of progression, or as surrogate end points for treat ment trials. 27 Examples of commonly used CVD surro gate bio markers include anatomical measures (carotid intima-media thickness [CIMT] and coronary artery calcification [CAC]), physio logical measures (blood pressure, endothelial function, and vascular stiffness) and soluble biomarkers (lipids and inflammatory markers). In addition, a growing body of research suggests that pedi atric cardiometabolic risk factors are in fact associated with noninvasive measures of vascular morphology and function. 28, 29 To be useful in pediatrics, the early presence of surrogate markers must predict later CVD. Potential shortcomings of surro gate markers in children include the facts that surrogates do not cause disease, are only part of a multipathway process, can be inappropriately sensitive or responsive to inter vention, could measure effects independent of inter ventions or often lack methodological standardization. 28 In 2009, the AHA published recommendations on the use of surrogate markers of CVD-including CIMT, CAC, endothelial function, and arterial stiffness-in pediatric patients. 29 The primary conclusion from this scientific statement was that risk factors associated with CVD develop ment are increasingly prevalent in youth, neces sitating develop ment and standardization of non invasive methods of CVD risk profiling to target the highest risk youths for the mostaggressive interventions. 29 In parti cular, an urgent need was identified for normative data specific for age, race, and sex, longitudinal studies to deter mine normal agerelated and pubertyrelated changes in the measures, correlations to betterestablished pediatric intermediate targetorgan end points (left ventricular hypertrophy, microalbuminuria), and studies to evaluate improvement in vascular function with treatment of cardiovascular risk factors. 29 Anatomical and physiological surrogates Early atherosclerosis can involve the endothelia of many arteries. The peripheral arteries can be measured noninva sively (a requisite for pediatric studies) and are, therefore, used as surrogates for the coronary arteries. CIMT is a marker of preclinical atherosclerosis associated with both the severity and extent of coronary artery disease (CAD) and predicts the likelihood of CVD events in adults. 30 In the Bogalusa Heart Study, participants were exam ined at least twice during childhood with an average fol lowup period of 26.4 years (final age 25-44 years). [31] [32] [33] Significant predictors of increased CIMT in adulthood were childhood plasma triglyceride levels in white males; LDLcholesterol levels in white and black females; SBP in white females and black males; and BMI in black females. Overall, childhood LDLcholesterol level and BMI, cumu lative LDLcholesterol and HDLcholesterol burden, and adult LDLcholesterol and HDLcholesterol levels, BMI, and SBP were associated with adult CIMT. 32, 33 The impact of childhood BMI on adult CIMT persisted even after adjustment for adult BMI. 33 Similarly, in the Young Finns Study of children aged 3-18 years assessed in 1980, child hood BMI, LDLcholesterol level, SBP, and smoking, and adult BMI, SBP, and smoking were associated with CIMT measured 21 years later. 34 The associations between child hood risk factors and adult atherosclerosis were stronger in men than in women, consistent with observed earlier CVD development in men. 34 The Muscatine study investi gators examined adults aged 33-42 years, who had been followed since the age of 8-18 years. Multivariate analysis demon strated that childhood BMI in women, and levels of total cholesterol and LDL cholesterol in childhood as well as adulthood age, in both sexes, predicted adult CIMT. 35 In a model incorporating CVD risk over time, childhood BMI and levels of LDL cholesterol and triglyc erides were predictive of CVD in women, and DBP and levels of LDL cholesterol and HDL cholesterol were pre dictive in men. 35 In the Muscatine study, aortic intimamedia thickness was found to correlate more strongly with CVD risk factors in adolescents than did CIMT in young adults. 36 Another method for estimating atherosclerosis is electron beam CT or spiral or helical CT imaging. Electronbeam CT is highly sensitive in defining the loca tion and extent of CAC, which predicts CAD, and future coronary events. 37 Mahoney et al. demonstrated a signifi cant relationship between levels of coronary risk factors measured during childhood and young adulthood and the presence of CAC in young adulthood. 38 Pediatric experi ence with CAC assessment is extremely limited. Gidding et al. demonstrated significant CAC in seven of 29 adoles cents and young adults with heterozygous familial hyper cholesterolemia, and that obesity increased the likelihood of CAC. 39 However, radiation exposure associ ated with CT currently limits its utility in most young people.
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Brachial artery reactivity assessment by ultrasono graphy, known as flowmediated dilation (FMD), is the most wellestablished technique to evaluate arterial func tion in adults. Impaired FMD correlates with CVD risk factors in adults and independently predicts CVD events. 40 Studies have shown that obese youths have reduced FMD, 41 even when compared with normalweight control indivi duals matched for blood pressure, chol esterol, and glucose, and that FMD correlated with BMI. 42 Thus, FMD appears to be a good predictor of CVD events in adults, and obesity already appears to be impacting FMD in youth. Arterial stiffness is another noninvasive surrogate marker of vascular health. In the Bogalusa Heart Study, decreased brachial distensibility was associated with greater adiposity, hypertension, and dyslipidemia in adults aged 19-37 years. 43 This measure has also been associated with increased CAC. 44 In children, brachial distensibility correlated inversely with total cholesterol level, 45 adiposity, DBP, inflammation, and insulin resistance. 46 In the Young Finns study, both childhood and adolescent CVD risk factors predicted abnormal pulse wave velocity in adult hood. 9 Therefore, childhood CVD risk factors, including BMI (especially in females), are associated with anatomical surrogates of CVD in adults. Additional data are needed on the predictive ability of anatomical surrogates used in youth on later adult CVD.
Metabolic syndrome
The metabolic syndrome (MetS) is a constellation of related factors known to increase the risk of developing CVD and T2D, 47 and is also (sometimes inappropriately) used as a surrogate for CVD. Owing to the dynamic effects of growth and puberty on cardiometabolic factors, the exact definition of pediatric MetS remains controversial, but its general components include obesity, insulin resis tance (hyper insulinemia, hyperglycemia), hypertension, dyslipidemia (low HDLcholesterol and high triglyceride levels), hepatic and visceral adiposity, and inflammation. 48 Few studies follow these factors from youth to adulthood; therefore, the extent to which pediatric MetS predicts adult CVD is unclear. In addition, components of child hood MetS are specific, but not sensitive, in predicting adult MetS.
As the prevalence and severity of pediatric obesity increases, so does the prevalence of childhood MetS, which occurs in 38.7% of moderately obese and 49.7% of severely obese youths. 49 In the National Heart, Lung, and Blood Institute Growth and Health study, 50 children who were overweight had significantly increased waist circum ference, SBP and DBP, and triglycerides levels, and lower levels of HDL cholesterol. Pediatric obesity is also associ ated with increased MetS prevalence in adulthood. In the Princeton Lipid Clinics Followup study, 51 adult MetS risk increased by 24% for every 10point increase in childhood BMI percentile. 51 Childhood BMI was the strongest pre dictor of adult MetS in the Muscatine study. 52 Adults with MetS in the Fels longitudinal study 53 had detectable differ ences in BMI by the age of 8 years in boys and by 13 years in girls, and in waist circumference by 6 years of age in boys and by 13 years in girls. Therefore, despite difficul ties in defining key components of the MetS, strong evi dence supports obesity, especially central, as an essential correlate of cardiometabolic risk. 53 In the Bogalusa Heart Study, clustering of MetS vari ables persisted over 8 years, more strongly than did individ ual MetS components, and the degree of cluster ing increased with increasing baseline age, BMI (unad justed or adjusted for insulin levels), and change in weight 
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Adult obesity Cardiovascular disease in adulthood REVIEWS over time. [54] [55] [56] 59 Thus, pediatric obesity increases the likelihood of MetS variable clustering, which, along with severity, persist over time and predict atherosclerosis as measured by CIMT and CAC. In the following sections, we review the evidence for the contribution of childhood obesity to the risk of each individual MetS component in adulthood.
Insulin resistance
Insulin resistance is considered to be an essential com ponent of the MetS, but its direct measurement with the hyperinsulinemiceuglycemic clamp method is relatively invasive and technically difficult to perform. Therefore, estimates such as fasting insulin and homeo static model assessment for insulin resistance (HOMA IR) are frequently employed as alternatives to direct measurement of insulin resistance. Limitations of these estimates include the lack of a normal range for insulin levels in children, poorly standardized insulin assays, loss of validity if the patient is not fasting, and failure to consider the impact of insulin clearance. 60 Fasting hyperinsulinemia, as a surro gate for insulin resistance, is associated with athero sclerosis and cardiovascular morbidity. 61 Evidence suggests that hyperinsulinemia itself might directly promote CVD 62 or, alternatively, that insulin is antiatherogenic, arguing that a lack of insulin action causes CVD. 63 In general, childhood obesity correlates with insulin resistance, as demonstrated by a hyperinsulinemic euglycemic clamp study in adolescents (Figure 2) , in which glucose disposal rate expressed per kg of body weight or per kg of fatfree mass was significantly lower in obese adolescents than in lean, control adolescents. 26 Similarly, BMI was the best predictor of insulin resistance by intra venous glucose tolerance testing in 97 healthy indivi duals aged 9.7-14.5 years. 64 In addition, among 243 obese chil dren aged 6-14 years, insulin level and HOMAIR were higher than in normalweight controls. 65 However, obesity is not synonymous with insulin resistance; obese youths with T2D are significantly more insulin resistant than youths without diabetes matched for age, sex, and BMI (Figure 2) . 66 Insulin resistance in obese youth varies by ethnicity, 67 and many studies show effects of insulin resistance on CVD outcomes, independent of BMI. [68] [69] [70] [71] In addition, cardiometabolic risk varies markedly in obese adults with the degree of insulin resistance. 72 In children aged 5-17 years from Bogalusa, LA, USA, BMI and adiposity correlated with fasting insulin, glucose, and insulin:glucose ratio. 68, [73] [74] [75] [76] Overweight youths had higher adult insulin and glucose levels, 55 and the preva lence of obesity was increased by 36fold among those whose insulin levels were consistently in the highest quartile 68 when compared with those consistently in the lowest quartile. In a cohort from Minneapolis, MN, USA, BMI in 13 yearolds was highly correlated with BMI and hyperinsulinemiceuglycemic clampderived glucose utiliza tion at age 22 years. 77 In addition, the rate of weight gain, starting at 7.7 years, correlated with fasting insulin levels in young adulthood (23.6 ± 0.2 years) in another cohort from Minneapolis. 78 Weight gain is fre quently ascribed to hyperinsulinemia; however, obesity was instead shown to lead to hyperinsulinemia in three longi tudinal cohorts (427 children, baseline age 5-7 years; 674 adolescents, baseline age 12-14 years; and 396 young adults, baseline age 20-24 years). 79 Moreover, another longitudinal cohort (n = 111, baseline age 9.7-14.5 years) demonstrated that children who are more insulin resis tant during puberty have decreased subcutaneous fat gain over puberty when compared with those who are less insulin resistant. 80 The relationship between plasma glucose and insulin levels and traditional CVD risk factors, even in chil dren without diabetes, suggests the importance of subtle abnormalities in carbohydrate metabolism early in the natural history of CVD. Progression to T2D confers an even higher risk of CVD than obesity alone and is increas ingly prevalent among young people, in parallel with the obesity epidemic, heralding a potential rise in the preva lence of early cardiovascular complications. 81 In a series of Early BMI rebound
Associated with increased adult BMI, [72] [73] [74] but not independent of childhood BMI, 75 and increased adult risk of T2D 74 and CHD in males of low birth weight 28, 29 Catch-up height gain
Associated with increased adult risk of CHD in previously short females 29 Abbreviations: CHD, coronary heart disease; CVD, cardiovascular disease; T2D, type 2 diabetes mellitus.
youths with T2D, 82 mean BMI ranged from 26-38 kg/m 2 ; thus, obesity is nearly universal in pediatric patients with T2D and is likely to contribute to future CVD. In pedi atric hyperinsulinemiceuglycemic clamp studies, both adi posity and insulin resistance independently predicted CVD risk factors, but adiposity and insulin resistance combined predicted greater CVD risk than the sum of individual risks. 70 
Hypertension
Crosssectional and longitudinal studies link pediat ric obesity to hypertension, a MetS component. In the Fels longitudinal cohort, childhood blood pressure mediated the effects of childhood BMI on adult hyper tension, but increased BMI, not increased blood pres sure, explained trends in adult hypertension. 83 Among 23,191 male and 3,789 female adolescents from the Metabolic Lifestyle and Nutrition Assessment in Young Adults cohort, BMI at the age of 17 years was strongly and independently associated with adult hypertension, even when adjusted for blood pressure at age 17 years, particularly in males. 84 BMI at age 30 years partially, but not completely, attenuated this association, particularly in girls. 84 In the Bogalusa Heart Study, childhood BMI and age of obesity onset predicted adult hypertension, but was attributable to the strong persis tence of weight status from childhood to adulthood.
14 Thus, additional data are needed to assess the independent relationship between childhood weight status and adult hyper tension. Regardless, pediatric hypertension associated with obesity cannot be ignored, as hyper tension in crosssectional studies of obese youths with T2D is docu mented to coexist with left ventricular hypertrophy as early as adolescence. 26 Dyslipidemia Dyslipidemia (high levels of triglycerides and low levels of HDL cholesterol) are additional MetS constituents contrib uting to CVD risk. In an analysis of data from the Young Finns, Bogalusa Heart, and Childhood Determinants of Adult Health (CDAH) studies, Magnussen et al. concluded that adolescent dyslipidemia is more strongly associ ated with adult CIMT than change in lipid levels over time, and that dyslipidemia combined with obesity is most strongly associated with increased CIMT. 85 In the Young Finns Study, participants with type IIb dyslipidemia (high LDLcholesterol and triglyceride levels) more commonly had obesity and MetS than a family history of early onset CHD, suggesting that lifestyle, rather than genetic influences, predominate in the atherogenic type IIb dyslipidemia phenotype. 86 Data from the Bogalusa Heart Study suggest that childhood nonHDLcholesterol levels persist and best predict adult dyslipidemia and other CVD risks. 14 Change in BMI over time was the next best predictor of adult dyslipi demia, 87 but was not independent of adult obesity.
14 Combined data from the CDAH, Young Finns, and Bogalusa Heart studies, indicated that childhood BMI was the best predictor of adult HDLcholesterol levels. 88 Of note, failure to account for expected fluctuations in lipid metabolism related to age, sex, and puberty could account for variability in some longitudinal data.
Hepatic and visceral adiposity
Hepatic and visceral adiposity are highly correlated with obesity and, independently, with all MetS components. In a large pediatric autopsy study, the prevalence of non alcoholic fatty liver disease (NAFLD) was four times higher in obese youth than in normalweight youth, after adjustment for age, sex, and ethnicity. 89 Elevated amino transferase levels have been reported in 10-25% of obese youth and in half of young people with T2D, suggesting hepatic inflammation. 90 The histological pattern of pediatric NAFLD differs from adults, and fibrosis is reported more commonly in children, 91 sup porting the idea that unique mechanisms might underlie pediatric NAFLD.
In the longitudinal West of Scotland coronary preven tion study, 92 NAFLD independently increased the risk of T2D and CVD. This association is likely to be caused by hepatic insulin resistance and overproduction of glucose, VLDL cholesterol, Creactive protein (CRP), and coagu lation factors. 93, 94 Thus, NAFLD is considered to be the hepatic component of the MetS. In the Bogalusa Heart Study, children who had persistently elevated amino transferase levels at 12 years of age had abnormal BMI, insulin resistance index, LDLcholesterol levels, and MetS variables. 95 Therefore, NAFLD and visceral adiposity are tightly tied to pediatric obesity and insulin resistance and, although often clinically silent in youth, appear to be a warning sign for future T2D and CVD. 
REVIEWS

Inflammation
Inflammatory cytokines are associated with CAD in adults, one of the most sensitive being CRP (high sensi tivity test; hsCRP), hence its frequent use as a CVD biomarker. 96 By contrast, the adipokine adiponectin is negatively correlated with CAD risk in adults, and could be a cardioprotective factor. 97 Including hsCRP as a MetS component has been proposed because inflammation might be necessary for full manifestation of MetS. 98 In a multivariate analysis of 1,083 individuals in their mid thirties from the Bogalusa Heart Study population, obesity, not estimated insulin resistance, was the major contributor to increased hsCRP levels. 99 Similarly, in 342 healthy youths aged 10-16 years from Minneapolis, hsCRP level was moststrongly related to adiposity. 100 After adjustment for adiposity, hsCRP differed by race (higher in black children than in white children), but was not significantly associated with fasting insulin, insulin resistance measured by hyperinsulinemiceuglycemic clamp, or other MetS criteria. 100 Finally, adiposity also appears to be the major determinant of hsCRP levels in pubertal children, with a small, independent effect of physical fitness. 101 Therefore, obesity appears to be indepen dently related to hsCRP from a very young age, but little longitudinal data exist for the stability of hsCRP over time or its predictive power for adult CVD when elevated in youth.
Childhood obesity and CVD
Theoretical data
In 2007, adolescent obesity in the USA was projected to increase obesity prevalence at age 35 years from 25% to 30-37% in men and from 32% to 34-44% in women by 2020. 102 These increases in obesity were projected to sub sequently raise the prevalence of CHD by 5-16%. 102 Such projections underscore the potential importance of wors ening childhood obesity on future CHD 103 and declining life expectancy, 104 especially since they could underesti mate the currently predicted future prevalence of CHD by not accounting for concurrent rising adult obesity rates or early atherogenesis caused by pediatriconset obesity.
Epidemiological data
Mortality data from American Indian youths-a popu lation particularly plagued by obesity and its complica tions-also indicate that children should be the focus of CVD mortality prevention. For example, among 4,857 American Indian children born between 1945 and 1984, endogenous death rates in the highest BMI quartile were 2.3 times as high as those in the lowest BMI quartile. 105 Similarly, in a British study of 2,399 children aged 2-14 years, an associ ation between childhood BMI and death from all causes and from ischemic heart disease was reported. 10 In a Danish study of 276,835 individuals, the risk of nonfatal and fatal CHD events in adulthood was associated with BMI at 7-13 years of age in males and BMI at 10-13 years of age in females. 11 The associ ations were linear for each age, and risk increased across the entire BMI distribution and with increasing child hood age. 11 Differences between the sexes were also noted in the Harvard growth study, where overweight adoles cents had an increased risk of CHD and atherosclerosis associated morbidity in adulthood. 12 However, CHD and allcause mortality was only increased among men who had been overweight in youth. 12 Childhood BMI was the only signifi cant predictor of adult left ventricu lar dilatation among participants in the Bogalusa Heart Study. 106 Finally, among a cohort of 37,674 prospectively followed Israeli male military personnel, elevated BMI at age 17 years was a significant predictor of T2D (hazard ratio [HR] for the lowest to highest decile 2.76, 95% CI 2.11-3.58) and of angiographically proven CHD (HR 5.43, 95% CI 2.77-10.62). 107 When controlling for current BMI, T2D was no longer associated with adoles cent BMI, but the associ ation with CHD was strengthened (HR 6.85, 95% CI 3.3-14.21), suggesting that the processes contri buting to CHD begin earlier and more gradually that those causing T2D. 107 Not all studies show positive associations between childhood BMI and CVD or mortality in adults, however. An investigation of 11,106 Scottish children (mean age 4.9 years) 108 and a metaanalysis of three studies (age range of participants 2-22 years) 109 did not detect effects of childhood BMI on CHD and ischemic heart disease in adulthood. Possible explanations for the negative findings were lack of statistical power, cohorts formed before the current obesity pandemic, or younger ages of children at entry where BMI might have reduced prognostic power. Moreover, high childhood BMI might be predictive only because it persisted as high adult BMI, rather than exert ing independent effects (Figure 1) . However, the result of the Harvard Growth Study refute this argument, as adolescent BMI independently and morepowerfully predicted CHD and overall morbidity and mortality than adulthood BMI. 12 Autopsy data CVD risk factors and surrogate markers are already identifi able in overweight children and appear to be amplified by obesity. However, the ultimate question is whether excess childhood weight has an impact on the hard outcomes of directly measured atherosclerosis, cardiovascular events, and death. Two early studies sug gested that heavier American 110 and Swedish 111 children had greater risk for CVD 110, 111 and mortality. 111 Autopsy analyses from the Bogalusa Heart 4 and PDAY 5 studies further demonstrated that the extent of early aortic and coronary atherosclerosis is directly associated with the severity of obesity in childhood and adolescence. In the PDAY study particularly, the findings of autopsy speci mens from individuals aged 15-34 years asserted the importance of nonlipid CVD risk factors in youth with a favorable lipoprotein profile 112 and that coronary athero sclerosis is significantly associated with BMI and visceral adiposity in young men. 
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14 studies with a total of 481 overweight youths. 113 The investigators concluded that 155-180 min per week of moderatetohigh intensity aerobic exercise reduces body fat in youth, but with inconclusive effects on weight and central adiposity. 113 A morerecent Cochrane meta analysis included 64 randomized, controlled primary pediatric obesity trials (n = 5,230), with at least 6 months of followup, that were published between 1985 and 2008. 114 Trials included lifestyle (six dietary, 12 physical activity, 36 behavioral) or drug (10 metformin, orlistat, or sibutramine) interventions versus standard care or self help. No surgical intervention studies met the inclusion criteria. The researchers concluded that lifestyle inter ventions improve weight at 6-12 months in children and adolescents, that orlistat or sibutramine (if tolerated) might be helpful additions in adolescents, and that future research should focus on psychosocial determinants of behavior change, strategies to improve clinician-family interaction, and costeffective primary care and com munity programs. 114 In 2010, Whitlock et al. reviewed 2,786 abstracts and 369 fulltext articles and found 15 "fairquality to goodquality" shortterm obesity trials of individuals aged 4-18 years. 13 Comprehensive mediumto highintensity behavioral interventions were determined the most effective (1.9-3.3 kg/m 2 difference in BMI favor ing intervention at 12 months), whereas combined inter ventions (behavioral change plus medication) resulted in small (orlistat 0.85 kg/m 2 ) or moderate (sibutramine 2.6 kg/m 2 ) BMI reductions in adolescents while on medi cation, but with a greater incidence of adverse effects. 13 Sibutramine was removed from the market in Europe and the USA on 8 October 2010 after clinical trials showed an increased risk of heart attacks and strokes among users. Approximately 39% of schoolbased studies showed a shortterm reduction in BMI, although insufficient evi dence existed regarding longterm efficacy of pediatric dietary interventions. The investigators concluded that, although inconsistent, overall findings suggest that school based physical activity interventions, particularly among girls, help prevent pediatric obesity in the shortterm. 116 Despite the large number of pediatric weightloss studies, data are lacking on the longterm effectiveness of such interventions. Additional areas for research in young people might include combinations of shortterm inter ventions (calorie restriction, appetite suppressants, or both) for initial weight loss, followed by longterm exer cise and lifestyle change for weight maintenance. Further research is also needed on screening tools and genetic predictors of response to calorie restriction, exercise, and appetite suppressant interventions, to allow a more cost effective focus on those young people who are most likely to respond to particular interventions.
Although surgical approaches to weight control are also being used in limited numbers of severely obese youths with substantial comorbidities, current studies are limited in size and number. Further study is required regarding the safety and longterm effectiveness of obesity surgery in youth. Regardless, neither currently available appetite suppressants nor surgery are adequately safe, Effects on metabolic syndrome components MetS components are modifiable determinants of adult CVD risk, and are suitable targets for interventions. In adults, weight loss of 10-15% of body weight improves glucose tolerance, and reduces waist circumference, visceral and hepatic fat, blood pressure, and insulin resistance. 117 The addition of physical activity increases HDLcholesterol levels, and further reduces waist circum ference and hepatic fat. 117 Exercise training improves insulin resistance and endothelial function beyond the benefits of glycemic and blood pressure control in children. 118 Among 126 children aged 6-14 years who reduced their standard deviation score of BMI (SDSBMI) in response to a 1year intervention (physical exercise, behavioral therapy, and education on nutrition), fasting insulin levels and HOMAIR improved significantly and were sustained 1 year after the intervention. 65 In a study by Reinehr and colleagues, a similar decrease in SDSBMI was observed among obese children aged 10-14 years who received a 1year lifestyle intervention (n = 124) or a 6week inpatient intervention (n = 119); however, only the longer, outpatient intervention reduced fasting insulin levels. 119 During a 1year obesity intervention program, BMISDS change was associated with change in HOMAIR among 57 obese children aged 6-14 years. 120 In addition, the results of a randomized, controlled trial showed that a 1year intensive familybased program including exercise, nutrition, and behavior modification improved BMI, HOMAIR, and blood pressure for up to 12 months in obese indivi duals aged 8-16 years. 121 Weight loss decreases the prevalence of pediatric NAFLD in a dose-response manner. 122 Nobili et al. showed that a 12month program of diet and physical exercise advice in youth (age 3.0-18.8 years) significantly decreased BMI, ultrasonographic steatosis, and fasting levels of glucose, insulin, lipids, and aminotransferases. 123 In small studies, metformin has been used effectively in adolescents with T2D to decrease BMI and improve glucose tolerance 124 and to improve aminotransferases, steatosis, and esti mated insulin resistance in youths with NALFD. 125 Levels of hsCRP and adiponectin also tend to improve with pediatric interventions that result in weight loss of ~5%, regardless of the type or length of intervention. 126 Thus, although success rates of pediatric weightloss programs are variable, clear improvements in surrogate markers of CVD occur when weight loss is actually achieved.
Effect on intermediate markers of CVD
An important public health question addressed by the Young Finns study 8 is whether improvement in CVD risk factors in young adulthood can reverse the effect of child hood risk factors on future atherosclerosis. Improvement in HDLcholesterol:LDLcholesterol ratio and obesity from childhood to adulthood was associated with reduced CIMT progression (Figure 3) . However, CIMT still pro gressed more than in participants who had normal base line and followup HDLcholesterol:LDLcholesterol ratio and BMI. 8 Frequent fruit intake and physical activity in childhood were also associated with lower adult CIMT. 8 Similarly, the number of CVD risk factors in childhood and adulthood in the Young Finns Study were associated with increased pulse wave velocity in adulthood, but reduction in the number of risk factors and improvement 
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in BMI over time were associated with lower pulse wave velocity in adulthood (Figure 4) . 9 Therefore, although pediatric lifestyle remains important, these data also suggest that vascular changes in childhood can at least be improved with appropriate improvement in CVD risk factors during young adulthood.
Conclusions
Strong evidence supports the concept that precursors of adult CVD begin in childhood, with obesity as an impor tant correlate of overall CVD risk. The clearest evidence comes from autopsy studies showing that coronary athero sclerotic lesions occur in early life and are strongly associ ated with pediatric obesity, hypertension, and dyslipi demia. Obesity and CVD risk factors tend to persist over time. Observations from pediatric epidemi ology studies over the past several decades further document that obesity, athero sclerosis, and associated risk factors begin in childhood. Lifestyle patterns, such as poor eating behavior, also begin early and influence CVD risk. The question of whether childhood obesity leads to increased adulthood CVD via increased CVD risk factors in childhood or via persistence into adulthood obesity, or both, remains unclear. However, sufficient data exist to warrant both obesity prevention and reduction in youth and adults.
Clearly, individuals who are both obese and have under lying risk factors for CVD, and their families, deserve the mostintensive interventions as these people are at high risk for CVD events and are mostlikely to benefit metabolically from weight loss. However, little evidence exists to suggest that adipose triglyceride deposition itself has a defined, independent role in CVD, which has led some to argue that young people with 'isolated obesity' should merely be monitored for development of other CVD risk factors, because interventions in this lowerrisk population might not be costeffective. Although a better understanding of these obese, insulinsensitive children is required, lifestyle interventions should still be consid ered in youths with isolated obesity owing to the likeli hood that they will continue to be obese as adults and will develop the morbid ities associated with adult obesity.
Normalweight children who become obese as adults are also at increased risk of adult morbidity, and under weight children who become obese adults could be at even higher risk of adult hypertension and renal disease than youths with higher weights. 110 Thus, excessive weight gain has negative consequences in all young people. Data show that established obesity is difficult to treat; there fore, early prevention efforts to avoid unhealthy lifestyles and encourage adoption of healthy behaviors are critical in all children and adolescents, not just those who are already obese. The pervasive nature of adult CVD indi cates that new strategies for populationbased approaches are also needed.
Several areas in pediatric obesity and CVD remain in need of research. Genetic abnormalities that cause severe early obesity have been identified. Affected genes include LEPR (leptin receptor), MC4R (melanocortin 4 receptor), and POMC (proopiomelanocortin). 127 However, these gene defects are rare and the remainder of the genome appears to have a minor role in the current obesity epidemic. Genes conferring increased risk for CVD have also been identi fied, but how these genes interact with obesity, or how obesityassociated genes interact with athero sclerosis is, as yet, unclear. Thus, we lack genetic insight into the relationships between obesity, MetS, and CVD. We also lack sufficient understanding of the inter mediate players and biomarkers in the relationship between obesity and CVD. A better understanding is required of the impact of elevated fasting glucose and glycated hemo globin levels, how they distribute in youth (especially during puberty), and their predictive value for longterm CVD outcomes. A limitation of our current approach to pedi atric obesity research is the reliance on surrogate markers, as we do not know how well abnormalities in surrogates such as CIMT or pulse wave velocity persist over time. Further research is required on biomarkers of insulin resistance in youth, their genetic basis, and their persis tence over time. Longitudinal studies, with large cohorts of youths, are now required to answer many of these areas of deficiency in our knowledge. Finally, better tools for prevention and treatment of childhood obesity are required, as none of the current methods are particularly successful or costeffective.
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